Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc.

New York startup Helaina, which ferments microbes to create recombinant breast milk proteins, is ushering in a new dawn for ...

The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of ...

The shingles vaccine might do just that. When most people think about vaccines, they picture protection against specific ...

Trump made the remarks on Wednesday at the 56th Annual Summit of the World Economic Forum in Davos, Switzerland. His comments came amid talks on global economic issues and shifting geopolitical ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

Identification of a nitric oxide-regulated transitional state of Müller glia reveals a key mechanism enabling neuronal regeneration in the injured vertebrate retina.

Genentech, considered one of the biotech industry’s founding companies, announced in May 2025 that it planned to build a $700 ...

Johns Hopkins researchers developed lipid nanoparticles to deliver therapeutic mRNA directly to the endometrium in mice. The ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Key market opportunities in the aquaculture vaccines sector include combating rising disease incidences via advanced vaccines ...